entity

polyglutamine

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about polyglutamine: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
1Hypotheses
1Analyses
0Outgoing
1Incoming
0Experiments
1Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (1)

SourceRelationTypeStr
HUNTINGTINaggregates_withprotein0.80

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Ataxin-2 Polyglutamine Expansions Hijack G3BP1 to Form Toxic 0.700 neurodegeneration How do disease-associated mutations in G

Mentioning Analyses (1)

Scientific analyses that reference this entity

Does DNAJB6 directly inhibit cross-seeding between tau, α-synuclein, and TDP-43

neurodegeneration | 2026-04-12 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (1)

Multi-agent debates referencing this entity

The debate revealed that DNAJB6 evidence is limited to polyglutamine aggregation

closed · Rounds: 4 · Score: 0.79 · 2026-04-16

Related Research

Hypotheses and analyses mentioning polyglutamine in their description or question text

No additional research found